Cronos Group Inc. to Speak at the 38th Annual ROTH Conference
Rhea-AI Summary
Cronos Group (NASDAQ: CRON) announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026 at 11:30 AM PDT.
A live webcast will be available via the company’s Investors site at https://ir.thecronosgroup.com/events-presentations, allowing investors to watch the presentation in real time.
Positive
- None.
Negative
- None.
News Market Reaction – CRON
In the Mar 16 session, CRON gained 1.60%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Earnings results | Positive | -3.6% | Reported record Q4 and full-year 2025 revenue and positive adjusted EBITDA. |
| Feb 17 | Product launch | Positive | +1.9% | Launched Spinach PUFFERZ™ all-in-one vape with high THC content. |
| Feb 12 | Conference call notice | Neutral | -1.5% | Announced date and time for Q4 and full-year 2025 earnings call. |
| Feb 02 | Market expansion | Positive | +0.0% | Launched premium Lord Jones® brand into the Israeli medical cannabis market. |
| Dec 09 | Acquisition announcement | Positive | +8.9% | Announced definitive deal to acquire CanAdelaar, leading Dutch adult-use operator. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive strategic and financial updates often produced mixed price reactions, with strong moves mainly around acquisition news, while product launches and brand expansions saw smaller or flat responses.
Over the last six months, Cronos reported strong 2025 results with net revenue of $146.6M and adjusted EBITDA of $10.1M, yet shares fell about 3.61% afterward. Product launches like Spinach PUFFERZ™ and the Lord Jones® expansion into Israel generated modest to flat moves. The announced CanAdelaar acquisition in the Netherlands drove an 8.91% gain, standing out as the most impactful catalyst. Compared with these events, today’s conference appearance is a routine investor-relations update.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, March 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026, at 11:30 AM PDT.
A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations.
About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, LIT™ and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Mr. Gorenstein’s intention to speak at the 38th Annual Roth Conference and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
Investor Relations Contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
